rs1062715

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015375.3(DSTYK):​c.2028C>T​(p.Phe676Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 1,613,754 control chromosomes in the GnomAD database, including 59,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7249 hom., cov: 32)
Exomes 𝑓: 0.26 ( 52282 hom. )

Consequence

DSTYK
NM_015375.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.66

Publications

17 publications found
Variant links:
Genes affected
DSTYK (HGNC:29043): (dual serine/threonine and tyrosine protein kinase) This gene encodes a dual serine/threonine and tyrosine protein kinase which is expressed in multiple tissues. It is thought to function as a regulator of cell death. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
DSTYK Gene-Disease associations (from GenCC):
  • congenital anomalies of kidney and urinary tract 1
    Inheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 23
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
  • complex hereditary spastic paraplegia
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 1-205160191-G-A is Benign according to our data. Variant chr1-205160191-G-A is described in ClinVar as [Benign]. Clinvar id is 260658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.66 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSTYKNM_015375.3 linkc.2028C>T p.Phe676Phe synonymous_variant Exon 8 of 13 ENST00000367162.8 NP_056190.1 Q6XUX3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSTYKENST00000367162.8 linkc.2028C>T p.Phe676Phe synonymous_variant Exon 8 of 13 1 NM_015375.3 ENSP00000356130.3 Q6XUX3-1
DSTYKENST00000367161.7 linkc.2028C>T p.Phe676Phe synonymous_variant Exon 8 of 12 1 ENSP00000356129.3 Q6XUX3-2

Frequencies

GnomAD3 genomes
AF:
0.300
AC:
45484
AN:
151854
Hom.:
7241
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.377
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.314
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.399
Gnomad SAS
AF:
0.413
Gnomad FIN
AF:
0.313
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.232
Gnomad OTH
AF:
0.300
GnomAD2 exomes
AF:
0.303
AC:
76058
AN:
251378
AF XY:
0.301
show subpopulations
Gnomad AFR exome
AF:
0.385
Gnomad AMR exome
AF:
0.339
Gnomad ASJ exome
AF:
0.288
Gnomad EAS exome
AF:
0.415
Gnomad FIN exome
AF:
0.314
Gnomad NFE exome
AF:
0.233
Gnomad OTH exome
AF:
0.261
GnomAD4 exome
AF:
0.261
AC:
381723
AN:
1461782
Hom.:
52282
Cov.:
37
AF XY:
0.264
AC XY:
192092
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.374
AC:
12530
AN:
33480
American (AMR)
AF:
0.341
AC:
15258
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
7544
AN:
26134
East Asian (EAS)
AF:
0.406
AC:
16132
AN:
39698
South Asian (SAS)
AF:
0.406
AC:
35059
AN:
86254
European-Finnish (FIN)
AF:
0.311
AC:
16601
AN:
53420
Middle Eastern (MID)
AF:
0.240
AC:
1384
AN:
5762
European-Non Finnish (NFE)
AF:
0.234
AC:
260469
AN:
1111924
Other (OTH)
AF:
0.277
AC:
16746
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
16431
32863
49294
65726
82157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9270
18540
27810
37080
46350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.300
AC:
45517
AN:
151972
Hom.:
7249
Cov.:
32
AF XY:
0.305
AC XY:
22670
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.377
AC:
15605
AN:
41444
American (AMR)
AF:
0.315
AC:
4808
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1021
AN:
3470
East Asian (EAS)
AF:
0.398
AC:
2050
AN:
5148
South Asian (SAS)
AF:
0.412
AC:
1984
AN:
4814
European-Finnish (FIN)
AF:
0.313
AC:
3305
AN:
10546
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.232
AC:
15749
AN:
67966
Other (OTH)
AF:
0.300
AC:
633
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1572
3144
4716
6288
7860
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.262
Hom.:
4206
Bravo
AF:
0.306
Asia WGS
AF:
0.393
AC:
1364
AN:
3478
EpiCase
AF:
0.236
EpiControl
AF:
0.227

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital anomalies of kidney and urinary tract 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 23 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
8.2
DANN
Benign
0.79
PhyloP100
2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1062715; hg19: chr1-205129319; COSMIC: COSV65688001; API